Send us Fan Mail

About Tony Sommer

Tony Sommer is the CEO of Treehouse Eyes and a respected leader in the vision care industry with more than 25 years of experience driving growth, innovation, and transformative healthcare solutions. Throughout his career, he has held executive leadership roles with industry-leading organizations including CooperVision, CIBA Vision, Bausch + Lomb, and Visioneering Technologies. Today, Tony is leading Treehouse Eyes' mission to expand access to pediatric myopia management, helping shape the future of children's vision care through clinical excellence, strategic partnerships, and innovation.

Send us Fan Mail

About Dr. Dalton Brothers

Dalton Brothers, O.D. is a proud third-generation optometrist, dedicated to advancing the field of eye care with innovative solutions. Dalton graduated from the University of Missouri Saint Louis College of Optometry in 2019 and has since joined his family's esteemed practice in Joplin, Missouri. He specializes in Ocular Aesthetics and Advanced Dry Eye, providing cutting-edge therapies such as Plate Rich Plasma, Intense Pulsed Light, and Photobiomodulation.

In 2021, Dalton expanded his passion for eye care by offering consulting services to fellow optometrists and ophthalmologists, helping them integrate these advanced therapies into their own clinics. Our mission is to empower eye care professionals with knowledge and innovative techniques aimed at enhancing patient outcomes.

Outside of the clinic, Dalton cherishes time spent with his wife and four daughters, bringing a family-oriented approach to his practice and strives to provide the highest level of care and expertise in every interaction.

Send us Fan Mail

About Cory Pinegar

Cory Pinegar is Chief Executive Officer of Utah-based CallForce, a groundbreaking dental service startup helping dental practices increase patient engagement and revenue. In 2016, at the age of 22, Cory struck gold and purchased the company—then named Recall Solutions—from software giant Weave for just one dollar. Since then, the visionary entrepreneur has grown CallForce from 35 clients to nearly 3,000 and with a workforce of close to 200 employees. CallForce has been named one of the fastest-growing companies by Inc. 500 and has been recognized repeatedly by the Salt Lake Tribune as one of the Best Places to Work.

In 2021, Cory founded the remote staffing company Teem, which helps simplify hiring international talent. Teem allows businesses to circumvent domestic staffing issues and find qualified talent without worrying about complicated research to understand legalities, fair compensation, and the like.

Cory sits on the boards of software-driven dental insurance verification company Verrific as well as The Parkinson's Foundation, devoted to finding a cure for the disease his father was diagnosed with in 2014.

Cory studied economics and business at Brigham Young University and spends his leisure time skiing, playing golf, and enjoying the mountain lifestyle.

Send us Fan Mail

About Dr. Browning

Christopher J. Browning, OD, is a Greenwood native who is proud to follow his dream of providing eye care to his wonderful community. As he has severe nearsightedness, Dr. Browning is passionate about using cutting-edge technology to help his patients achieve excellent vision, particularly through contact lenses.

Learn more

Send us Fan Mail

About Dr. Harbir Sian OD

Dr. Harbir Sian is the co-owner of three optometric practices in British Columbia. In the clinic, Dr. Sian enjoys practicing various specialties within eyecare, particularly myopia management and dry eye.

After completing his Doctor of Optometry degree from the New England College of Optometry in 2010, Dr. Sian found that he was passionate about giving back to those who have less access to care and about educating the public and professionals in various settings.

Over the years, Harbir has volunteered in multiple mobile vision clinics, including global clinics South America and in the Middle East. He has taken his passion for education to countless stages and conferences around North America, including giving a TEDx talk titled "Our Eyes Are The Windows to Our Soul”, which shared the magic and power of the human visual system. Harbir was named as one of the Contact Lens Institute’s 2025 Visionaries. He is also the host of Canada’s number 1 optometry podcast, The 20/20 Podcast which showcases successful guests from various industries and backgrounds.

Send us Fan Mail

Mr. Dempsey brings more than two decades of domestic and global experience in the ophthalmic space, driving successful drug development, business transactions, and commercialization. Mr. Robert’s CEO and Board Director experience spans extensive transaction and portfolio expertise across venture capital, investment banking, and strategies to successfully secure funding and advance M&A opportunities for multiple companies. His professional network in the eye care community is broad and well-established, complemented by his philanthropic leadership as Co-Founder and Board Member of the Holland Foundation for Sight Restoration. Robert also serves as an independent director on multiple ophthalmic
Boards.

Mr. Dempsey currently serves as Chief Executive Officer of OKYO Pharma, a public, clinical-stage biopharmaceutical company developing investigational therapies for neuropathic corneal pain (NCP) and inflammatory eye diseases. The company’s lead candidate, urcosimod, has received FDA Fast Track designation for treating NCP. Previously, Mr. Dempsey served as Interim Chief Executive Officer of Ashvattha Therapeutics, where he led development of Migaldendranib (MGB), a novel targeted nanomedicine platform designed to normalize VEGF expression for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Earlier in his career, Mr. Dempsey served as President and Chief Executive Officer of AsclepiX Therapeutics, where he oversaw the rapid clinical development of a new chemical entity targeting ocular diseases and cancer through naturally occurring, self-regulating homeostatic pathways. Prior to that, he served as Chief Executive Officer of TearClear, where he accelerated the company’s business and commercial strategy, leading to multiple value-inflection points, including a successful Series B financing and positive FDA engagements.

Mr. Dempsey formerly served as the Group Vice President and Head of Global Ophthalmology at Shire, which was acquired by Takeda, and was responsible for closing one of only 3 ophthalmology transactions with >$1B upfront in the last 2 decades for Xiidra that transacted again 4 years later for $1.7B to Bausch & Lomb.
At Shire, he swiftly established a highly regarded reputation for Shire as a new company in the ophthalmology and optometry markets. Leading the commercialization strategy that resulted in an industry-leading launch, while overseeing the acquisition of four companies that contributed to the franchise pipeline of innovative candidates aimed at improving vision-related quality, was an
accomplishment about which he is most proud.

In his spare time, he enjoys spending time with family on the lake and watching Boston sports.

Here's another episode about neuropathic pain on The OI Show: https://theoishow.buzzsprout.com/1601521/episodes/15618641-167-the-oi-show-neuropathic-pain-with-kaleb-abbott

Send us Fan Mail

Rob Sambursky, MD, has more than 25 years of experience spanning the life sciences industry and clinical medicine. He is a fellowship-trained cornea specialist and currently serves as Chief Executive Officer of DefEYE, Inc..

Prior to joining DefEYE, Dr. Sambursky was one of the original founders of RPS Diagnostics and served as President and Chief Executive Officer of both RPS Diagnostics and Lumos Diagnostics. He led Lumos Diagnostics through its initial
public offering on the Australian Securities Exchange. In addition, he was a founder and Executive Chairman of Visus Therapeutics . Throughout his executive leadership roles, Dr. Sambursky also served as acting Chief Medical Officer for RPS Diagnostics, Lumos Diagnostics, and DefEYE.

Dr. Sambursky currently serves as a strategic advisor to Tenpoint Therapeutics and is Board Chair of Advanced Ophthalmics, Inc. and Sustained Drug Delivery, Inc. He has extensive scientific and clinical expertise in ophthalmology, infectious disease, and medical sciences, and has served as an advisory board consultant to numerous ophthalmic therapeutic companies. Dr. Sambursky has authored dozens of patents and scientific publications, conceived a novel point-of-care diagnostic platform, and served as the clinical and regulatory lead supporting multiple international regulatory clearances and U.S. FDA 510(k) clearances with CLIA-waived designations. He has also played a key role in the successful commercialization of multiple diagnostic products in the United States and internationally.

Dr. Sambursky is a practicing, board-certified ophthalmologist with fellowship training in corneal, external, and infectious disease. He earned a BA in Biology from Brown University, an MA in Medical Sciences with concentrations in biochemistry and microbiology from Boston University, and an MD from Boston University School of Medicine. He completed his medical internship at Mount Auburn Hospital, affiliated with Harvard Medical School, and completed both his ophthalmology residency and cornea fellowship at Wills Eye Hospital, where he also served as Co-Chief Resident.

Send us Fan Mail

About Dr. Volkert

Dr. Kayla Volkert is the founder and optometrist behind See La Vie Eyecare & Eyewear, a boutique eye care practice she opened in 2022 with the goal of bringing personalized, state-of-the-art eye care to the Main Line.

Originally from York, Pennsylvania, Dr. Volkert now lives in Bryn Mawr with her husband and their two young sons. She loves the walkability, charm, and strong sense of community that make the Main Line such a special place to live and raise a family—and she is proud to serve the neighborhood she calls home.

Dr. Volkert earned her undergraduate degree from Penn State University, where she majored in Life Sciences and minored in French and Psychology. During college, she spent a semester studying abroad in Montpellier, France—an experience that shaped her appreciation for culture, connection, and thoughtful design.

She earned her Doctor of Optometry degree from the New England College of Optometry in Boston, where she was inducted into the Beta Sigma Kappa Honor Society and received clinical honors across her rotations. While in optometry school, Dr. Volkert served as President of the Private Practice Club, reflecting her long-standing interest in improving the patient experience and building a practice rooted in personalized care. Her clinical training included advanced rotations at Bascom Palmer Eye Institute, with a focus on pediatric contact lenses, and the Baltimore VA, where she gained extensive experience in the diagnosis and management of ocular disease.

After graduation, Dr. Volkert practiced optometry in Charleston, South Carolina for several years before returning to Pennsylvania to open See La Vie. Through her practice, she combines medical expertise with an elevated, boutique approach to eye care—offering comprehensive eye exams, advanced technology, and a highly personalized experience designed to help patients look, see, and feel their best.